Allscripts (MDRX) Reports In-Line Q2 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/25/2026
- Nasdaq lags on angst over AI spending ahead of earnings reports
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- Intel jumps 10% after AI-fueled quarter crushes estimates, upbeat outlook
- Oil falls on report China pushing for end US-Iran war
- Why Meta, Microsoft, and Nvidia are championing open-weight AI
- FDA approves Tylenol with Naproxen as first OTC combo pain reliever
- AMD (AMD) PT Raised to $1,250 at Baird
- Pakistan, Iran explore path towards new talks with US in a China-initiated push, sources say
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- Nasdaq lags on angst over AI spending ahead of earnings reports
Allscripts announces second quarter 2017 results
August 3, 2017 4:04 PM EDTAll-time record bookings total $407 million, 12 percent growth year-over-yearNew client business totals over one-third of bookings; revenue backlog at a record $4.1 billionRevenue $426 million, $428 million non-GAAP, growth of 10 and 8 percent respectively year-over-yearAllscripts to acquire hospital and health system business from McKesson Corporation
CHICAGO, Aug. 03, 2017 (GLOBE NEWSWIRE) -- Allscripts Healthcare Solutions, Inc. (NASDAQ: MDRX) (Allscripts) announced its financial results for the three and six months ended June 30, 2017.
Second Quarter and Recent Business Highlights
... More
